Business and Science

economic evaluation models. According to the authors, traditional approaches to assessing investment opportunities fall short in the pharmaceutical industry. At a time when the healthcare industry is placing increasing emphasis on licensing as a core strategy this book provides a firm understanding of the way in which products and businesses can be valued at all stages of their development, while their thorough treatment of quantitative approaches to the valuation of companies provides a solid theoretical and practical framework for all of those involved in financing the new generation of biotechnology companies. This book has quickly become the standard reference in the industry. Both the authors introduce the characteristics of medical device development and drug, explain how to translate these into the valuation, and provide valuable industry data. The book also contains abundant case studies and exercises which clearly exemplify the most difficult theories. Methods and models for the evaluation of projects and companies are carefully described and explained and will thus provide a practical and rational basis for negotiations. More sophisticated Valuation is a hot topic among life sciences professionals. This evaluation techniques are necessary, particularly in respect of the book deals specifically with Valuation in Life Science. As this is drug development process, intellectual property evaluation, the focus issue for anyone involved in business development like: licensing and sublicensing. The book presents a number of industry professionals, investors, and academics. This book will innovative ideas, illustrated with practical examples, that should be of immense value to strategic planning, licensing and improve decision-making in these areas. The authors make a business development, corporate finance professionals and convincing case for the use of advanced techniques and the senior managers in all sectors of the life sciences industry. section on worked-examples should be particularly interesting to This book is structured in five parts. In first part that is in practitioners. Unique importance is put on the practicability of introduction, Author discuss the role of players in life sciences the projected methods by including many hands-on examples, industry and describe why valuation is important to them. The without compromising on practical results. second part deals with the input parameters required for There is no doubt that this book will become an essential valuation in life sciences. In the third part author discuss the reference tool for professionals in technology transfer, business principles of valuation. The fourth part is the core of book and …